Table 2.
Crude and age-standardized cancer incidence rates by sex in Korea, 2017
| Site/Type | Crude incidence rate per 100,000 |
Age-standardized incidence rate per 100,000a) |
||||
|---|---|---|---|---|---|---|
| Both sexes | Men | Women | Both sexes | Men | Women | |
| All sites | 453.4 | 478.1 | 428.6 | 264.4 | 291.3 | 251.5 |
| Lip, oral cavity, and pharynx | 7.2 | 10.3 | 4.1 | 4.3 | 6.3 | 2.4 |
| Esophagus | 4.8 | 8.8 | 1.0 | 2.6 | 5.1 | 0.5 |
| Stomach | 57.9 | 77.9 | 38.1 | 32.0 | 46.4 | 19.6 |
| Colon and rectum | 54.9 | 65.1 | 44.7 | 29.7 | 38.8 | 21.8 |
| Liverb) | 30.1 | 45.0 | 15.2 | 16.5 | 26.8 | 7.2 |
| Gallbladderc) | 13.4 | 13.9 | 12.8 | 6.6 | 8.0 | 5.5 |
| Pancreas | 13.7 | 14.6 | 12.9 | 7.1 | 8.5 | 5.8 |
| Larynx | 2.4 | 4.5 | 0.3 | 1.3 | 2.6 | 0.1 |
| Lungd) | 52.7 | 72.9 | 32.5 | 27.1 | 42.1 | 15.5 |
| Breast | 43.7 | 0.4 | 86.9 | 28.0 | 0.2 | 55.6 |
| Cervix uteri | 6.8 | - | 13.5 | 4.4 | - | 8.7 |
| Corpus uteri | 5.8 | - | 11.6 | 3.7 | - | 7.3 |
| Ovary | 5.3 | - | 10.5 | 3.4 | - | 6.8 |
| Prostate | 25.0 | 50.0 | - | 12.9 | 28.9 | - |
| Testis | 0.5 | 1.0 | - | 0.5 | 1.0 | - |
| Kidney | 10.3 | 14.1 | 6.6 | 6.3 | 8.9 | 3.8 |
| Bladder | 8.5 | 13.8 | 3.3 | 4.3 | 8.0 | 1.5 |
| Brain and CNS | 3.8 | 4.1 | 3.6 | 2.9 | 3.1 | 2.7 |
| Thyroid | 51.1 | 23.6 | 78.5 | 36.8 | 17.0 | 57.2 |
| Hodgkin lymphoma | 0.6 | 0.7 | 0.4 | 0.5 | 0.6 | 0.4 |
| Non-Hodgkin lymphoma | 9.3 | 10.6 | 8.0 | 6.0 | 7.4 | 4.8 |
| Multiple myeloma | 3.2 | 3.4 | 3.0 | 1.7 | 2.0 | 1.5 |
| Leukemia | 6.6 | 7.5 | 5.7 | 5.2 | 6.2 | 4.3 |
| Other and ill-defined | 35.9 | 36.2 | 35.6 | 20.6 | 23.2 | 18.5 |
CNS, central nervous system.
a)
Age-adjusted using Segi’s world standard population,
b)
Includes the liver and intrahepatic bile duct,
c)
Includes the gallbladder and other/unspecified parts of the biliary tract,
d)
Includes the lung and bronchus.